• CMS Delays Enforcement of Medicare Physician Signature Requirement Three Months

    December 21, 2010
    FOR IMMEDIATE RELEASE: DECEMBER 21, 2010 Contact: JoAnne Glisson American Clinical Laboratory Association (202) 637-9466 CMS DELAYS ENFORCEMENT OF MEDICARE PHYSICIAN SIGNATURE REQUIREMENT THREE MONTHS; ACLA VOWS TO WORK WITH CMS TOWARD WORKABLE ALTERNATIVES TO REQUIREMENT TO AVOID DISRUPTION OF PATIENT ACCESS TO LABORATORY SERVICES Washington DC – The American Clinical Laboratory Association (ACLA) appreciates the Centers for Medicare and Medicaid Services’ (CMS)Continue Reading »...
  • ACLA Urges Immediate Action by Congress to Extend Technical Component “Grandfather”

    December 01, 2010
    Washington DC – The American Clinical Laboratory Association (ACLA) today joined nine other health care organizations in sending a letter to the House Ways & Means and Senate Finance Committees’ leadership urging swift action to extend the Technical Component (TC) “Grandfather” set to expire this year on December 31st. The TC “Grandfather” would ensure that hospitals can continue to rely on independent laboratories toContinue Reading »...
  • Clinical Laboratory Industry on Role for FDA in Regulating Laboratory Developed Tests

    July 16, 2010
    July 16, 2010 For Immediate Release Contacts: Alan Mertz, 202-637-9466; David Mongillo, 202-637-9466; Clinical Laboratory Industry on Role for FDA in Regulating Laboratory Developed Tests “21st Century tests require 21st Century Solutions” Washington, DC — The Food and Drug Administration can promote progress toward personalized medicine by approaching the oversight of laboratory developed tests (LDTs) in a focused, flexible, and balanced wayContinue Reading »...
  • The Genome Project: A Balance Sheet

    June 15, 2010
    To the Editor: Mapping the human genome was not just about finding cures. It was also about understanding disease so we could provide better care. That is now happening in spades throughout the health system. Genetic tests can identify the exact molecular nature of a patient or disease, allowing for better prevention and targeted treatment. The cure rate for childhood leukemia now exceeds 80Continue Reading »...
  • ACLA Supports Physician Guidance in Patient-Centered Genetic Testing

    May 12, 2010
    Washington DC – Consumers should seek the guidance of a personal physician or other health care provider in the use of direct to consumer genetic tests to ensure proper understanding of the results and appropriate follow-up, said the American Clinical Laboratory Association (ACLA) today. Recent media reports of genetic tests being marketed and sold directly to consumers in drug stores and other retail establishmentsContinue Reading »...
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15